Safety and efficacy of immune checkpoint inhibitors in persons with HIV at a single, tertiary care cancer center in the United States
These findings suggest that HIV status alone should not preclude use of ICI therapy to improve prognosis among PWH and cancer.
Authors
- Anna E. Coghill (ORCID: https://orcid.org/0000-0001-7142-7499)
- Nathan Van Bibber
- Kathryn Lurain (ORCID: https://orcid.org/0000-0002-5794-7292)
- Allison I. Graeter
- Kristina Bowles (ORCID: https://orcid.org/0000-0002-1091-0978)
- Ramya Ramaswami (ORCID: https://orcid.org/0000-0001-5709-4675)
- J. M. Robertson
Institutions
- University of South Florida (US)
- Moffitt Cancer Center (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- AIDS
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1097/qad.0000000000004380
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00